Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Social dominance affects intake rate and behavioral time budget in pre-pubertal dairy heifers allocated in continuous competitive situations.

Fiol C, Aguerre M, Carriquiry M, Ungerfeld R.

Animal. 2019 Jun;13(6):1297-1303. doi: 10.1017/S1751731118002835. Epub 2018 Oct 23.

PMID:
30348233
2.

Social dominance in prepubertal dairy heifers allocated in continuous competitive dyads: Effects on body growth, metabolic status, and reproductive development.

Fiol C, Carriquiry M, Ungerfeld R.

J Dairy Sci. 2017 Mar;100(3):2351-2359. doi: 10.3168/jds.2016-11840. Epub 2017 Jan 11.

3.

Positive effects of biostimulation on luteinizing hormone concentration and follicular development in anestrous beef heifers.

Fiol C, Ungerfeld R.

J Anim Sci. 2016 Mar;94(3):971-7. doi: 10.2527/jas.2015-9396.

PMID:
27065259
4.

Genetic selection for temperament affects behaviour and the secretion of adrenal and reproductive hormones in sheep subjected to stress.

Hawken PA, Luckins N, Tilbrook A, Fiol C, Martin GB, Blache D.

Stress. 2013 Jan;16(1):130-42. doi: 10.3109/10253890.2012.690114. Epub 2012 Jun 19.

PMID:
22564112
5.

Genetic differences in temperament determine whether lavender oil alleviates or exacerbates anxiety in sheep.

Hawken PA, Fiol C, Blache D.

Physiol Behav. 2012 Mar 20;105(5):1117-23. doi: 10.1016/j.physbeh.2011.12.005. Epub 2011 Dec 13.

PMID:
22192707
6.

Response to biostimulation in peri-puberal beef heifers: influence of male-female proximity and heifer's initial body weight.

Fiol C, Quintans G, Ungerfeld R.

Theriogenology. 2010 Sep 1;74(4):569-75. doi: 10.1016/j.theriogenology.2010.03.015. Epub 2010 May 23.

PMID:
20494426
7.

Separately together. Achieving physician-administrator collaboration through single purpose.

O'Connor EJ, Fiol CM.

Healthc Exec. 2010 Jan-Feb;25(1):72, 74-5. No abstract available.

PMID:
20108600
8.

Beating them or joining them: your radiology group's path to the future.

O'Connor EJ, Liebscher LA, Fiol CM.

J Am Coll Radiol. 2004 Oct;1(10):755-61. Review.

PMID:
17411696
9.

Carrying the load together.

O'Connor EJ, Fiol CM.

Physician Exec. 2007 Jan-Feb;33(1):68-70. No abstract available.

PMID:
17355007
10.

Handling emotional reactions to change.

O'Oconnor EJ, Fiol CM.

Physician Exec. 2006 Nov-Dec;32(6):78-80. No abstract available.

PMID:
17176718
11.

Reclaiming physician power: your role as a physician executive.

O'Connor Ej, Fiol CM.

Physician Exec. 2006 Nov-Dec;32(6):46-50. No abstract available.

PMID:
17176711
12.

Moving from resistance to support.

O'Connor EJ, Fiol CM.

Physician Exec. 2006 Sep-Oct;32(5):68-9. No abstract available.

PMID:
17007318
13.

Do your people want to do what is needed?

O'Connor EJ, Fiol CM.

Physician Exec. 2006 Jul-Aug;32(4):58-61. No abstract available.

PMID:
16889299
14.

Separately together--build unity by strengthening physician groups.

O'Connor EJ, Fiol CM, Guthrie M.

Physician Exec. 2006 Jul-Aug;32(4):16-21. No abstract available.

PMID:
16889291
15.

Creating organizational support for change.

O'Connor EJ, Fiol CM.

Physician Exec. 2006 May-Jun;32(3):76-8. No abstract available.

PMID:
16736639
16.

Building the relationships required to influence others.

O'Connor EJ, Fiol CM.

Physician Exec. 2006 Mar-Apr;32(2):68-9. No abstract available.

PMID:
16615409
17.

Creating readiness and involvement.

O'Connor EJ, Fiol CM.

Physician Exec. 2006 Jan-Feb;32(1):72-4. No abstract available.

PMID:
16509406
18.

Focusing your people: the power of entrepreneurial thinking.

O'Connor EJ, Fiol CM.

Physician Exec. 2006 Jan-Feb;32(1):18-23. No abstract available.

PMID:
16509395
19.

Resistance to patient safety initiatives.

O'Connor EJ, Fiol CM.

Physician Exec. 2005 Nov-Dec;31(6):64-7. No abstract available.

PMID:
16382656
20.

Clarifying your vision and objectives.

O'Connor EJ, Fiol CM.

Physician Exec. 2005 Jul-Aug;31(4):64-5. No abstract available.

PMID:
16285175
21.

Moving into and through transitions.

O'Connor EJ, Fiol CM.

Physician Exec. 2005 Sep-Oct;31(5):64-5. No abstract available.

PMID:
16224913
22.

Following a proven path to success.

O'Connor EJ, Fiol CM.

Physician Exec. 2005 May-Jun;31(3):77-8. No abstract available.

PMID:
16048170
23.

Getting from here to there in health care.

O'Connor EJ, Fiol CM.

Physician Exec. 2005 Mar-Apr;31(2):56-8. No abstract available.

PMID:
15844802
24.

Spinning a winning web: attracting and retaining top performers.

O'Connor EJ, Fiol CM.

Physician Exec. 2004 Sep-Oct;30(5):40-2.

PMID:
15506534
25.

Relation between leptin and body fat distribution in menopausal status.

Martínez-Carpio PA, Fiol C, Hurtado I, Arias C, Ruiz E, Orozco P, Corominas A.

J Physiol Biochem. 2003 Dec;59(4):301-7.

PMID:
15164950
26.

Putting your money where your people are: investing in enduring success.

O'Connor EJ, Fiol CM.

Physician Exec. 2003 Jul-Aug;29(4):12-5. No abstract available.

PMID:
14650065
27.

Naked reverse: unexpected plays for exceptional results.

O'Connor EJ, Fiol CM, Dewil G.

Physician Exec. 2003 Sep-Oct;29(5):28-33.

PMID:
14531182
28.

Time and your future.

O'Connor EJ, Fiol CM.

Mich Health Hosp. 2003 Sep-Oct;39(5):30-1. No abstract available.

PMID:
14503031
29.

Plant the seeds for success. Peace Corps provides lesson for building leadership support.

O'Connor EJ, Fiol CM.

MGMA Connex. 2003 Aug;3(7):17-8. No abstract available.

PMID:
12959048
30.

From "them" to "us". Going where others have gone before.

O'Connor EJ, Fiol CM.

Mich Health Hosp. 2003 Jul-Aug;39(4):34-6.

PMID:
12886658
31.

When hot and cold collide: riding the spirals of emotion and logic.

O'Connor EJ, Fiol CM.

Physician Exec. 2002 Nov-Dec;28(6):18-21. No abstract available.

PMID:
12448137
32.

Diving into white lightning. Health behaviors in group practices.

O'Connor EJ, Fiol CM.

MGMA Connex. 2002 Oct;2(9):22-4. No abstract available.

PMID:
12380214
33.

[Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].

Martínez Castelao A, Ramos R, Serón D, Gil-Vernet S, Fiol C, Gómez-Gerique N, Yzaguirre MT, Hurtado I, Sabaté I, Alsina J, Grinyó JM.

Nefrologia. 2002;22(4):364-9. Spanish.

34.

Mindful over mindless: learning to think like an entrepreneur.

O'Connor EJ, Fiol CM.

Physician Exec. 2002 Jul-Aug;28(4):18-23. No abstract available.

PMID:
12219526
35.

Improvement in endothelial dysfunction in patients with hypoalphalipoproteinemia and coronary artery disease treated with bezafibrate.

Meco JF, Vila R, Pujol R, Bros R, Domènech P, Fiol C, Pintó X.

J Cardiovasc Pharmacol. 2001 Aug;38(2):250-8.

PMID:
11483875
36.

Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis.

Salazar A, Maña J, Fiol C, Hurtado I, Argimon JM, Pujol R, Pinto X.

Atherosclerosis. 2000 Oct;152(2):497-502.

PMID:
10998479
37.

Liver xenotransplantation: changes in lipid and lipoprotein concentration after long-term graft survival.

Molleví DG, Jaurrieta E, Ribas Y, Hurtado I, Serrano T, Gómez N, de Oca J, Fiol C, Figueras J.

J Hepatol. 2000 Apr;32(4):655-60.

PMID:
10782915
38.

[Efficacy of hygienic and dietary therapy in coronary patients with isolated hypoalphalipoproteinemia].

Meco JF, Pinto X, Quintana E, Fiol C, Castiñeiras MJ, Pujol R.

An Med Interna. 1999 Dec;16(12):620-5. Spanish.

PMID:
10686713
39.

Alterations of lipoprotein metabolism in a concordant model of liver xenotransplantation.

Molleví DG, Ribas Y, Jaurrieta E, Gómez N, de Oca J, Fiol C, Figueras J.

Transplant Proc. 1999 Sep;31(6):2620-1. No abstract available.

PMID:
10500746
40.

Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients.

Martínez-Castelao A, Grinyó JM, Fiol C, Castiñeiras MJ, Hurtado I, Gil-Vernet S, Serón D, Porta I, Miñarro A, Villarroya A, Alsina J.

Kidney Int Suppl. 1999 Jul;71:S231-4.

PMID:
10412785
41.

[Changes in low density lipoprotein susceptibility to oxidation after wine ingestion].

Caldú P, Hurtado I, Ramon JM, Antolí R, Gonzalo A, Mínguez S, Fiol C.

Med Clin (Barc). 1998 Oct 17;111(12):451-5. Spanish. No abstract available.

PMID:
10026035
42.

Low levels of high density lipoprotein cholesterol in patients with active sarcoidosis.

Salazar A, Maña J, Pinto X, Argimon JM, Castiñeiras MJ, Fiol C, Pujol R.

Atherosclerosis. 1998 Jan;136(1):133-7.

PMID:
9580477
43.

Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli.

Allegrini S, Pesi R, Tozzi MG, Fiol CJ, Johnson RB, Eriksson S.

Biochem J. 1997 Dec 1;328 ( Pt 2):483-7.

44.

Physician executive leadership. Leading the way.

O'Connor EJ, Fiol CM.

Physician Exec. 1997 Nov-Dec;23(8):6-13.

PMID:
10176691
45.

Molecular basis of fish-eye disease in a patient from Spain. Characterization of a novel mutation in the LCAT gene and lipid analysis of the cornea.

Blanco-Vaca F, Qu SJ, Fiol C, Fan HZ, Pao Q, Marzal-Casacuberta A, Albers JJ, Hurtado I, Gracia V, Pintó X, Martí T, Pownall HJ.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1382-91.

PMID:
9261271
46.

[Risk factors of arteriopathy of the lower extremities: lipid and not lipid factors].

Pintó X, Fiol C, Simeón JM, Capdevila JM, Barjau E, Argimón JM, Moga I, Pujol R.

Med Clin (Barc). 1997 Jun 7;109(2):41-4. Spanish.

PMID:
9280799
47.

In vitro oxidised HDL exerts a cytotoxic effect on macrophages.

Hurtado I, Fiol C, Gracia V, Caldú P.

Atherosclerosis. 1996 Aug 23;125(1):39-46. Erratum in: Atherosclerosis 1996 Nov 15;127(1):143.

PMID:
8831925
48.

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P.

Science. 1996 May 17;272(5264):1023-6.

PMID:
8638126
49.

White wine reduces the susceptibility of low-density lipoprotein to oxidation.

Caldú P, Hurtado I, Fiol C, Gonzalo A, Mínguez S.

Am J Clin Nutr. 1996 Mar;63(3):403-4. No abstract available.

PMID:
8602601
50.

Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.

Ribera M, Pintó X, Argimon JM, Fiol C, Pujol R, Ferrándiz C.

Am J Med. 1995 Nov;99(5):485-90.

PMID:
7485205

Supplemental Content

Support Center